(Q44202794)

30 November 2017

title

Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report (English)

1 reference

30 November 2017

S B Sinclair

1

1 reference

30 November 2017

G A Levy

series ordinal

2

1 reference

30 November 2017

publication date

1 June 1991

1 reference

30 November 2017

number of pages

10

1 reference

Digestive Diseases and Sciences

inferred from page(s)

published in

1 reference

30 November 2017

volume

36

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

791-800

1 reference

Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils

30 November 2017

cites work

1 reference

12 December 2020

Fulminant and subfulminant liver failure: definitions and causes

1 reference

12 December 2020

Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage

1 reference

12 December 2020

Hepatits A virus infection in fulminant hepatitis and chronic active hepatitis

1 reference

12 December 2020

Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes

1 reference

12 December 2020

The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model

1 reference

12 December 2020

Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen.

1 reference

12 December 2020

Viral particles induce Ia antigen expression on astrocytes

1 reference

12 December 2020

Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

1 reference

12 December 2020

Vigorous medical management of acute fulminant hepatitis

1 reference

12 December 2020

The effect of prostaglandins, branched-chain amino acids and other drugs on the outcome of experimental acute porcine hepatic failure

1 reference

12 December 2020

Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators

1 reference

12 December 2020

Modulation of inflammation and immunity by cyclic AMP.

1 reference

12 December 2020

Emergency liver transplantation for fulminant hepatitis

1 reference

12 December 2020

16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection

1 reference

12 December 2020

Hepatitis type A, B, and non-A non-B in fulminant hepatitis

1 reference

12 December 2020

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

1 reference

12 December 2020

Fulminant hepatic failure

1 reference

12 December 2020

Inhibitory effects of prostaglandin E1 on T-cell mediated cytotoxicity against isolated mouse liver cells

1 reference

12 December 2020

Orthotopic liver transplantation for fulminant and subacute hepatic failure

1 reference

12 December 2020

Prostaglandins modulate macrophage Ia expression

1 reference

12 December 2020

The Biosynthesis and Metabolism of Prostaglandins

1 reference

12 December 2020

Expression of class I and class II major histocompatibility complex antigens on human hepatocytes

1 reference

12 December 2020

The functional significance of the regulation of macrophage Ia expression by endogenous arachidonate metabolites in vitro

1 reference

12 December 2020

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

12 December 2020

Prostaglandin E inhibits the production of human interleukin 2

1 reference

12 December 2020

Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animals

1 reference

12 December 2020

Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features

1 reference

12 December 2020

Charcoal hemoperfusion. Plus ça change, plus c'est la même chose

1 reference

12 December 2020

A possible role for prostaglandin E1 as a modulator for temperature regulation in the central nervous system of the cat

1 reference

12 December 2020

Effect of prostacyclin (PGI2) and a prostaglandin analogue BW 245C on galactosamine-induced hepatic necrosis

1 reference

12 December 2020

Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver

1 reference

12 December 2020

Orthotopic liver transplantation for acute and subacute hepatic failure in adults

1 reference

12 December 2020

Studies on the mechanism of the protective action of 16,16-dimethylPGE2 in carbon tetrachloride induced acute hepatic injury in the rat.

1 reference

12 December 2020

Subacute hepatic failure; is it a distinct entity?

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01311239

1 reference

30 November 2017

1 reference